PHOENIX, March 8, 2022 /PRNewswire/ -- Creative
Medical Technology Holdings, Inc. ("Creative Medical Technology" or
the "Company") (NASDAQ: CELZ), a leading commercial stage
biotechnology company focused on a regenerative approach to
immunotherapy, urology, neurology, and orthopedics, today announced
that Company executives will be participating in the
34th Annual Roth Conference to be held March 13-15, 2022 in Dana Point, California. Management will be
available for one-on-one meetings throughout the
conference.
To learn more about the conference and submit a registration
request, please visit:
https://ibn.fm/ROTH2022Registration.
A copy of the Company's latest investor presentation, which will
be used during one-on-one meetings, can be found on Creative
Medical Technology's IR website at:
https://creativemedicaltechnology.investorroom.com/.
About Creative Medical Technology Holdings
Creative Medical Technology Holdings, Inc. is a commercial stage
biotechnology company specializing in stem cell technology in the
fields of immunotherapy, urology, neurology, and orthopedics. For
further information about the company, please visit
www.creativemedicaltechnology.com.
About Roth Capital Partners
Roth Capital Partners, LLC ("Roth") is a relationship-driven
investment bank focused on serving emerging growth companies and
their investors. As a full-service investment bank, Roth provides
capital raising, M&A advisory, analytical research, trading,
market-making services, and corporate access. Headquartered in
Newport Beach, California, Roth is
privately held and owned by its employees and maintains offices
throughout the U.S. For more information on Roth, please visit
www.roth.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/creative-medical-technology-to-participate-in-the-34th-annual-roth-conference-301496930.html
SOURCE Creative Medical Technology Holdings, Inc.